SB-715992 in Treating Patients With Metastatic or Recurrent Malignant Melanoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Christopher Lee, MD
BCCA - Fraser Valley Cancer Centre
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- British Columbia Cancer Agency - Centre for the Southern Interior
Kelowna, British Columbia, Canada
- Fraser Valley Cancer Centre at British Columbia Cancer Agency
Surrey, British Columbia, Canada
- British Columbia Cancer Agency - Vancouver Cancer Centre
Vancouver, British Columbia, Canada
- Nova Scotia Cancer Centre at Queen Elizabeth Ii Health Sciences Centre
Halifax, Nova Scotia, Canada
- Margaret and Charles Juravinski Cancer Centre
Hamilton, Ontario, Canada
- Toronto Sunnybrook Regional Cancer Centre at Sunnybrook and Women'S College Health Sciences Centre
Toronto, Ontario, Canada
- Centre Hospitalier de L'Universite de Montreal
Montreal, Quebec, Canada
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Nov 2004
- Primary completion
- 30 Sept 2006
- Completion
- 30 Sept 2008
- Last update posted
- 17 May 2013
- Registered enrollment
- 17
- Registry id
- NCT00095953
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.